Recent Articles

Be Careful Before Loving Leveraged Biotech ETFs

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs. More 

3 Charts That Tell Us About the Stock Market in October

The economy continues to struggle, employment is still weak, and markets are vulnerable. Here's how we're going to position our portfolio More 

Biotech Stocks: Is It Safe to Come out Now? (IBB, XBI)

Biotech stocks are getting smashed this week, but betting against the sector remains a bad idea. The only trick is getting the timing right. More 

The Best Way to Buy Biotech Stocks: A Heated Debate

Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers. More 

7 Dirt-Cheap Ways to Supercharge Your Portfolio

Looking to juice your dividends? Get aggressive with growth? Well, these are some of the best ETFs to get the job done on the cheap. More 

The 7 Best ETFs to Buy for June

The best ETFs to buy as we head into summer are those that are on the right side of some powerful macro trends. Here are seven that fit that bill right now. More 

Biotech Stocks Set to Soar, So Buy This Top Biotech ETF

Biotech stocks are NOT in a bubble, and the XBI biotech ETF is a cheap and diversified way to play the long-term potential of biotechnology. More